DESOUZA ERROL B 4
4 · Royalty Pharma plc · Filed May 14, 2025
Insider Transaction Report
Form 4
DESOUZA ERROL B
Director
Transactions
- Award
Class A Ordinary Shares
2025-05-13+7,614→ 81,352 total
Footnotes (1)
- [F1]Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.